The lack of recent insider transactions and low insider owne...

The lack of recent insider transactions and low insider ownership at Dyne Therapeutics doesn't inspire confidence. Insider sales at prices above current levels could suggest contentment with lower valuations, potentially a weak sign for future stock performance.